Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
4126
DELISTED
Avantax, Inc. Common Stock
AVTA
| $869K | ﹤0.01% |
168,432
-164,476
| -49% | -$1.16M |
|
|
SPNC
4127
DELISTED
Spectranetics Corp
SPNC
| $867K | ﹤0.01% |
59,690
-5,614
| -9% | -$77.7K |
|
4128
CALL
Rockwell Automation
ROK
$50.1B
| $865K | ﹤0.01% |
7,600
+1,100
| +17% | +$112K |
|
4129
PUT
Vanguard Real Estate ETF
VNQ
$39.2B
| $863K | ﹤0.01% |
+10,300
| New | +$802K |
|
4130
CALL
Infosys
INFY
$50.5B
| $862K | ﹤0.01% |
90,600
+33,600
| +59% | +$293K |
|
|
CPXX
4131
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $862K | ﹤0.01% |
+78,182
| New | +$256K |
|
|
IMGN
4132
PUT
DELISTED
Immunogen Inc
IMGN
| $861K | ﹤0.01% |
+101,100
| New | +$855K |
|
|
4133
PUT
Infosys
INFY
$50.5B
| $860K | ﹤0.01% |
90,400
-95,000
| -51% | -$828K |
|
4134
TTEC Holdings
TTEC
$128M
| $860K | ﹤0.01% |
30,987
+2,868
| +10% | +$76.8K |
|
4135
CALL
T. Rowe Price
TROW
$24.5B
| $859K | ﹤0.01% |
11,700
-3,200
| -21% | -$222K |
|
4136
CALL
Norwegian Cruise Line
NCLH
$9.32B
| $857K | ﹤0.01% |
15,500
+12,200
| +370% | +$588K |
|
4137
National CineMedia
NCMI
$384M
| $855K | ﹤0.01% |
5,619
+143
| +3% | +$21.4K |
|
4138
PUT
C.H. Robinson
CHRW
$17.9B
| $854K | ﹤0.01% |
11,500
-11,400
| -50% | -$782K |
|
|
LBY
4139
DELISTED
Libbey, Inc.
LBY
| $854K | ﹤0.01% |
45,869
+34,794
| +314% | +$611K |
|
|
DEL
4140
DELISTED
Deltic Timber
DEL
| $854K | ﹤0.01% |
14,198
+2,981
| +27% | +$168K |
|
|
BPMC
4141
DELISTED
Blueprint Medicines
BPMC
| $853K | ﹤0.01% |
47,238
-46,481
| -50% | -$806K |
|
|
TEP
4142
CALL
DELISTED
Tallgrass Energy Partners, LP
TEP
| $851K | ﹤0.01% |
22,200
+16,600
| +296% | +$580K |
|
4143
CALL
Pacific Biosciences
PACB
$404M
| $850K | ﹤0.01% |
100,000
+25,000
| +33% | +$246K |
|
4144
PUT
Dover
DOV
$28.3B
| $849K | ﹤0.01% |
16,342
+9,533
| +140% | +$462K |
|
4145
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.96B
| $848K | ﹤0.01% |
13,672
+6,786
| +99% | +$385K |
|
|
CHL
4146
CALL
DELISTED
China Mobile Limited
CHL
| $848K | ﹤0.01% |
15,300
-34,600
| -69% | -$1.87M |
|
|
AVX
4147
DELISTED
AVX Corporation
AVX
| $847K | ﹤0.01% |
67,385
+27,739
| +70% | +$323K |
|
|
AXON
4148
Axon Enterprise
AXON
$49.1B
| $846K | ﹤0.01% |
43,084
-44,020
| -51% | -$755K |
|
4149
CALL
ICICI Bank
IBN
$109B
| $846K | ﹤0.01% |
130,020
+69,960
| +116% | +$410K |
|
4150
PUT
PNC Financial Services
PNC
$102B
| $846K | ﹤0.01% |
10,000
-72,300
| -88% | -$6.16M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.